Thursday, 19 December 2019

In Depth Market Analysis, Growth, Size, Up-Coming Trends and Demand of Pharmaceutical Intermediates Market Forecast to reach with CAGR 6.1% by 2024


A fresh report titled “Pharmaceutical Intermediates Market - By End User (Pharmaceutical Companies, Research Labs, Contract Manufacturing Organizations and Others) & Global Region - Market Size, Trends, Opportunity, Forecast 2018-2024” has been presented Fast Market Research. It evaluates the key market trends, advantages, and factors that are pushing the overall growth of the market. The report also analyzes the different segments along with major geographies that have more demand for Pharmaceutical Intermediates Market. The competition analysis is also a major part of the report.

Access Sample Copy of This Report - https://www.fastmr.com/request-s/31

Global pharmaceutical intermediates market is anticipated to reach USD 38,457.2 Million by the end of 2024 from USD 27,356.1 Million in 2018. The global pharmaceutical intermediates market is expected to flourish at a CAGR of 6.1% during the forecast period i.e. 2019-2024. Pharmaceutical intermediates manufacturers are investing heavily in the development of new intermediates. The market is also expected to significantly benefit from this. In addition, patent expiry is also supposed to positively impact the growth of the global pharmaceutical intermediate market. Apart from this, continuous demand for new and innovative therapies are offering promising growth of pharmaceutical intermediates market over the forecast period.
Market Dynamics

Growth Drivers – Pharmaceutical Intermediates Market

Rising Production of APIs

Increasing production of active pharmaceutical ingredients is accelerating the demand for pharmaceutical intermediates. Further, increasing trend towards new high tech therapeutics coupled with the development of innovative delivery systems and innovation in personalized medicine is believed to further emphasize the growing demand for the active pharmaceutical market. This bodes well for global pharmaceutical intermediates market.
Due to a rise in the demand for quality APIs, there is growing investment in research & development for API production which will result in increased demand for pharmaceutical intermediates.

Increasing Prevalence of Diseases

Rising prevalence of various infectious and chronic diseases is resulting in increased demand for pharmaceuticals which, in turn, is spearheading current and future growth of pharmaceutical intermediates market. According to the CDC (Centers for Disease Control and Prevention), there were around 16.8 million physician visits for infectious and parasitic diseases in the United States. Further, supportive government healthcare initiatives are believed to garner the growth of the market in the years ahead.

Barriers – Pharmaceutical Intermediates Market

Strong Competition in Industry

The pharmaceutical industry comprises of a large pool of small, medium & giant manufacturers of pharmaceutical intermediates. Apart from this, the number of contract manufacturing organizations are also increasing especially in the Asia Pacific region which has also increased market competition across the globe.

Issues witnessing Overall Pharmaceutical Industry

Regulatory requirements are tightening and will likely continue to do so with a push for more transparency in the supply chain in the future. These increasing regulatory-related issues have brought difficulties for pharmaceutical intermediate suppliers across the globe.

Pricing Challenges

The prices of intermediates are moving up as regulatory-related expenses such as fees related to the Generic Drug User Fee Act in the U.S. are increasing. This unstable pricing trend is adversely affecting the supplying network of the intermediates.

Market Trends

Product Portfolio Expansion

Pharmaceutical intermediates companies are expanding their businesses in terms of product offering and regional markets. This expansion trend is benefiting manufacturers by allowing them to deliver more advanced one-stop solutions to their customers. For instance, AGC Inc. has recently expanded its facilities at its Chiba Plant that resulted in an approximately tenfold increase in the company’s GMP1-compliant synthetic pharmaceutical intermediate and active ingredient2 production capacity.

Market Segmentation

By End User:
- Pharmaceutical Companies
- Research Labs
- Contract Manufacturing Organizations
- Others

By Geography
- North America (U.S. & Canada)
- Europe (Germany, United Kingdom, France, Italy, Spain, Russia and Rest of Europe)
- Asia Pacific (China, India, Japan, South Korea, Indonesia, Taiwan, Australia, New Zealand and Rest of Asia Pacific)
- Latin America (Brazil, Mexico, Argentina and Rest of Latin America)
- Middle East & Africa (GCC, North Africa, South Africa and Rest of the Middle East & Africa)

Competitive Landscape
The report profiles various major market players such as
• Aceto
• Eastar
• BASF SE
• Midas Pharma
• A.R. Life Sciences Pvt. Ltd.
• Lianhetech
• Arkema
• Hangzhou FST Pharmaceutical
• Chemcon Specialty Chemical Pvt. Ltd.
• Vertellus Holdings LLC
• Other Major & Niche Players

Browse Complete Report With Table of Content- https://www.fastmr.com/report/31/pharmaceutical-intermediates-market

Table of Content

Research Methodology

Market Definition and List of Abbreviations

1. Executive Summary
2. Growth Drivers & Barriers in Global Pharmaceutical Intermediates Market
3. Global Pharmaceutical Intermediates Market Trends
4. Opportunities in Global Pharmaceutical Intermediates Market
5. Recent Industry Activities, 2018
6. Porter's Five Forces Analysis
7. Market Value Chain and Supply Chain Analysis
8. Global Pharmaceutical Intermediates Market Value (USD Million) Forecast & Y-o-Y Growth Analysis, 2018-2024

9. Global Pharmaceutical Intermediates Market Segmentation Analysis, By End User
9.1. Introduction
9.2. Market Attractiveness, By End User
9.3. BPS Analysis, By End User
9.4. Pharmaceutical Companies Market Value (USD Million) Forecast & Y-o-Y Growth Analysis, 2018-2024
9.5. Research Labs Market Value (USD Million) Forecast & Y-o-Y Growth Analysis, 2018-2024
9.6. Contract Manufacturing Organizations Market Value (USD Million) Forecast & Y-o-Y Growth Analysis, 2018-2024
9.7. Other Market Value (USD Million) Forecast & Y-o-Y Growth Analysis, 2018-2024

10. Geographical Analysis
10.1. Introduction
10.2. North America Market Value (USD Million) Forecast & Y-o-Y Growth Analysis, 2018-2024
10.2.1. By End User
10.2.1.1. Introduction
10.2.1.2. Market Attractiveness, By End User
10.2.1.3. BPS Analysis, By End User
10.2.1.4. Pharmaceutical Companies Market Value (USD Million) Forecast & Y-o-Y Growth Analysis, 2018-2024
10.2.1.5. Research Labs Market Value (USD Million) Forecast & Y-o-Y Growth Analysis, 2018-2024
10.2.1.6. Contract Manufacturing Organizations Market Value (USD Million) Forecast & Y-o-Y Growth Analysis, 2018-2024
10.2.1.7. Other Market Value (USD Million) Forecast & Y-o-Y Growth Analysis, 2018-2024
10.2.2. By Country
10.2.2.1. Introduction
10.2.2.2. Market Attractiveness, By Country
10.2.2.3. BPS Analysis, By Country
10.2.2.4. U.S. Market Value (USD Million) Forecast & Y-o-Y Growth Analysis, 2018-2024
10.2.2.5. Canada Market Value (USD Million) Forecast & Y-o-Y Growth Analysis, 2018-2024

10.3. Europe Market Value (USD Million) Forecast & Y-o-Y Growth Analysis, 2018-2024
10.3.1. By End User
10.3.1.1. Introduction
10.3.1.2. Market Attractiveness, By End User
10.3.1.3. BPS Analysis, By End User
10.3.1.4. Pharmaceutical Companies Market Value (USD Million) Forecast & Y-o-Y Growth Analysis, 2018-2024
10.3.1.5. Research Labs Market Value (USD Million) Forecast & Y-o-Y Growth Analysis, 2018-2024
10.3.1.6. Contract Manufacturing Organizations Market Value (USD Million) Forecast & Y-o-Y Growth Analysis, 2018-2024
10.3.1.7. Other Market Value (USD Million) Forecast & Y-o-Y Growth Analysis, 2018-2024
10.3.2. By Country
10.3.2.1. Introduction
10.3.2.2. Market Attractiveness, By Country
10.3.2.3. BPS Analysis, By Country
10.3.2.4. Germany Market Value (USD Million) Forecast & Y-o-Y Growth Analysis, 2018-2024
10.3.2.5. United Kingdom Market Value (USD Million) Forecast & Y-o-Y Growth Analysis, 2018-2024
10.3.2.6. France Market Value (USD Million) Forecast & Y-o-Y Growth Analysis, 2018-2024
10.3.2.7. Italy Market Value (USD Million) Forecast & Y-o-Y Growth Analysis, 2018-2024
10.3.2.8. Spain Market Value (USD Million) Forecast & Y-o-Y Growth Analysis, 2018-2024
10.3.2.9. Russia Market Value (USD Million) Forecast & Y-o-Y Growth Analysis, 2018-2024
10.3.2.10. Rest of Europe Market Value (USD Million) Forecast & Y-o-Y Growth Analysis, 2018-2024

10.4. Asia Pacific Market Value (USD Million) Forecast & Y-o-Y Growth Analysis, 2018-2024
10.4.1. By End User
10.4.1.1. Introduction
10.4.1.2. Market Attractiveness, By End User
10.4.1.3. BPS Analysis, By End User
10.4.1.4. Pharmaceutical Companies Market Value (USD Million) Forecast & Y-o-Y Growth Analysis, 2018-2024
10.4.1.5. Research Labs Market Value (USD Million) Forecast & Y-o-Y Growth Analysis, 2018-2024
10.4.1.6. Contract Manufacturing Organizations Market Value (USD Million) Forecast & Y-o-Y Growth Analysis, 2018-2024
10.4.1.7. Other Market Value (USD Million) Forecast & Y-o-Y Growth Analysis, 2018-2024
10.4.2. By Country
10.4.2.1. Introduction
10.4.2.2. Market Attractiveness, By Country
10.4.2.3. BPS Analysis, By Country
10.4.2.4. China Market Value (USD Million) Forecast & Y-o-Y Growth Analysis, 2018-2024
10.4.2.5. India Market Value (USD Million) Forecast & Y-o-Y Growth Analysis, 2018-2024
10.4.2.6. Japan Market Value (USD Million) Forecast & Y-o-Y Growth Analysis, 2018-2024
10.4.2.7. South Korea Market Value (USD Million) Forecast & Y-o-Y Growth Analysis, 2018-2024
10.4.2.8. Indonesia Market Value (USD Million) Forecast & Y-o-Y Growth Analysis, 2018-2024
10.4.2.9. Taiwan Market Value (USD Million) Forecast & Y-o-Y Growth Analysis, 2018-2024
10.4.2.10. Australia Market Value (USD Million) Forecast & Y-o-Y Growth Analysis, 2018-2024
10.4.2.11. New Zealand Market Value (USD Million) Forecast & Y-o-Y Growth Analysis, 2018-2024
10.4.2.12. Rest of Asia Pacific Market Value (USD Million) Forecast & Y-o-Y Growth Analysis, 2018-2024

10.5. Latin America Market Value (USD Million) Forecast & Y-o-Y Growth Analysis, 2018-2024
10.5.1. By End User
10.5.1.1. Introduction
10.5.1.2. Market Attractiveness, By End User
10.5.1.3. BPS Analysis, By End User
10.5.1.4. Pharmaceutical Companies Market Value (USD Million) Forecast & Y-o-Y Growth Analysis, 2018-2024
10.5.1.5. Research Labs Market Value (USD Million) Forecast & Y-o-Y Growth Analysis, 2018-2024
10.5.1.6. Contract Manufacturing Organizations Market Value (USD Million) Forecast & Y-o-Y Growth Analysis, 2018-2024
10.5.1.7. Other Market Value (USD Million) Forecast & Y-o-Y Growth Analysis, 2018-2024
10.5.2. By Country
10.5.2.1. Introduction
10.5.2.2. Market Attractiveness, By Country
10.5.2.3. BPS Analysis, By Country
10.5.2.4. Brazil Market Value (USD Million) Forecast & Y-o-Y Growth Analysis, 2018-2024
10.5.2.5. Mexico Market Value (USD Million) Forecast & Y-o-Y Growth Analysis, 2018-2024
10.5.2.6. Rest of Latin America Market Value (USD Million) Forecast & Y-o-Y Growth Analysis, 2018-2024

More Info@@

About Us:

FAST.MR is a global market research and business-consulting organization that aims to provide a deep market insight to our clients, which helps them in better decision making in the dynamic environment. We have a team of highly qualified personnel that studies the market in depth to provide our clients with better strategies to stand out in the market.

Contact Us:

Jason Lee
150 State Street, Albany,
New York, USA 12207
+1 (518) 300-1215
Follow UsFacebook, Twitter, Linked In

No comments:

Post a Comment